Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Explore clinical trials studying Anti-N-Methyl-D-Aspartate Receptor Encephalitis. Study availability and eligibility vary by location and protocol.

7 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Anti-N-Methyl-D-Aspartate Receptor Encephalitis trial results

Recruiting

Efgartigimod in Anti-NMDA Receptor Encephalitis.

NCT07822776

Conditions: Anti-N-Methyl-D-Aspartate Receptor Encephalitis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +13 more
Locations: Beijing Tongren Hospital,Capital Medical University, Beijing, Beijing 100730 Beijing, China

View Trial Details

Recruiting

Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis

NCT06867991

Conditions: Anti-N-Methyl-D-Aspartate Receptor Encephalitis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +12 more
Locations: The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China

The First People's Hospital of Changzhou Changzhou, Jiangsu, China

View Trial Details

Recruiting

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

NCT05017142

Conditions: Acute Disseminated Encephalomyelitis, Anti-AMPAR-1/2 Associated Autoimmune Encephalitis, Anti-CASPR-2 Associated Autoimmune Encephalitis, +61 more
Locations: Kantonsspital Aarau Aarau, Canton of Aargau, Switzerland

Children's Hospital of Eastern Switzerland Sankt Gallen, Canton of St. Gallen, Switzerland

University Children's Hospital Lausanne (CHUV) Lausanne, Canton of Vaud, Switzerland

Kantonsspital Winterthur Winterthur, Canton of Zurich, Switzerland

View all 13 locations

View Trial Details

Recruiting

Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis

NCT06510283

Conditions: Anti-N-Methyl-D-Aspartate Receptor Encephalitis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +12 more
Locations: Beijing Tongren Hospital,Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Completed

Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis

NCT03274375

Conditions: Anti-N-Methyl-D-Aspartate Receptor Encephalitis, Anti-NMDAR Encephalitis, Autoimmune Diseases, +13 more
Locations: Hôpital Necker Enfants-Malades Paris, France

View Trial Details

Completed

A Case Report of NMDAR Encephalopathy

NCT06915103

Conditions: Anti-N-Methyl-D-Aspartate Receptor Encephalitis, Anti-NMDA Receptor Encephalitis, Autoimmune Diseases, +19 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Completed

Transcranial Direct Current Stimulation on Cortical Plasticity in Patients With Anti-NMDA Receptor Encephalitis

NCT01865578

Conditions: Anti-N-Methyl-D-Aspartate Receptor Encephalitis, Anti-NMDA Receptor Encephalitis, Autoimmune Diseases, +13 more
Locations: Charite University Medicine Berlin, State of Berlin, Germany

View Trial Details

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate Receptor Encephalitis trial results

Efgartigimod in Anti-NMDA Receptor Encephalitis.

Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis

Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis

A Case Report of NMDAR Encephalopathy

Transcranial Direct Current Stimulation on Cortical Plasticity in Patients With Anti-NMDA Receptor Encephalitis

Related conditions